200,000+ products from a single source!

sales@angenechem.com

Home > Indoles and Oxindole > 130308-48-4

130308-48-4

130308-48-4 | L-Arginine, D-arginyl-L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-(3R)-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-(2S,3aS,7aS)-octahydro-1H-indole-2-carbonyl-

CAS No: 130308-48-4 Catalog No: AG000U9B MDL No:MFCD00213940

Product Description

Catalog Number:
AG000U9B
Chemical Name:
L-Arginine, D-arginyl-L-arginyl-L-prolyl-(4R)-4-hydroxy-L-prolylglycyl-3-(2-thienyl)-L-alanyl-L-seryl-(3R)-1,2,3,4-tetrahydro-3-isoquinolinecarbonyl-(2S,3aS,7aS)-octahydro-1H-indole-2-carbonyl-
CAS Number:
130308-48-4
Molecular Formula:
C59H89N19O13S
Molecular Weight:
1304.5225
MDL Number:
MFCD00213940
IUPAC Name:
(2S)-2-[[(2S,3aS,7aS)-1-[(3R)-2-[(2S)-2-[[(2S)-2-[[2-[[(2S,4R)-1-[(2S)-1-[(2S)-2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]-4-hydroxypyrrolidine-2-carbonyl]amino]acetyl]amino]-3-thiophen-2-ylpropanoyl]amino]-3-hydroxypropanoyl]-3,4-dihydro-1H-isoquinoline-3-carbonyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid
InChI:
InChI=1S/C59H89N19O13S/c60-37(14-5-19-67-57(61)62)48(82)72-38(15-6-20-68-58(63)64)52(86)75-22-8-18-43(75)54(88)77-30-35(80)26-44(77)50(84)70-28-47(81)71-40(27-36-13-9-23-92-36)49(83)74-41(31-79)53(87)76-29-34-12-2-1-10-32(34)24-46(76)55(89)78-42-17-4-3-11-33(42)25-45(78)51(85)73-39(56(90)91)16-7-21-69-59(65)66/h1-2,9-10,12-13,23,33,35,37-46,79-80H,3-8,11,14-22,24-31,60H2,(H,70,84)(H,71,81)(H,72,82)(H,73,85)(H,74,83)(H,90,91)(H4,61,62,67)(H4,63,64,68)(H4,65,66,69)/t33-,35+,37+,38-,39-,40-,41-,42-,43-,44-,45-,46+/m0/s1
InChI Key:
QURWXBZNHXJZBE-SKXRKSCCSA-N
SMILES:
OC[C@@H](C(=O)NC(=N)NCCC[C@H](N(C(=O)[C@@H]1NCc2c(C1)cccc2)C(=O)C1N[C@@H]2[C@H](C1)CCCC2)C(=O)O)NC(=O)[C@H](Cc1cccs1)NC(=O)CNC(=O)[C@@H]1C[C@H](CN1C(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](CCCNC(=N)N)N)CCCNC(=N)N)O
UNII:
7PG89G35Q7

Properties

Complexity:
2720  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
12  
Defined Bond Stereocenter Count:
0
Exact Mass:
1303.661g/mol
Formal Charge:
0
Heavy Atom Count:
92  
Hydrogen Bond Acceptor Count:
18  
Hydrogen Bond Donor Count:
15  
Isotope Atom Count:
0
Molecular Weight:
1304.541g/mol
Monoisotopic Mass:
1303.661g/mol
Rotatable Bond Count:
30  
Topological Polar Surface Area:
552A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-6.4  

Literature

Title Journal
Kinin B2 receptor deletion and blockage ameliorates cisplatin-induced acute renal injury. International immunopharmacology 20140901
Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency. Expert review of clinical immunology 20130501
Icatibant for the treatment of hereditary angioedema. The Annals of pharmacotherapy 20130101
Hereditary angioedema: epidemiology, management, and role of icatibant. Biologics : targets & therapy 20130101
Managing hereditary angioedema patients undergoing otolaryngeal procedures. American journal of rhinology & allergy 20130101
Interaction between bradykinin and natriuretic peptides via RGS protein activation in HEK-293 cells. American journal of physiology. Cell physiology 20121215
The high glucose-induced stimulation of B1R and B2R expression via CB(1)R activation is involved in rat podocyte apoptosis. Life sciences 20121102
Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors. The American journal of emergency medicine 20121001
An update on hereditary angioedema. Current opinion in pediatrics 20121001
Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems. Expert opinion on pharmacotherapy 20121001
[Several new treatment possibilities of hereditary angio-oedema]. Ugeskrift for laeger 20120820
Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study. Allergy 20120801
Current management options for hereditary angioedema. Current allergy and asthma reports 20120801
Gangliosides stimulate bradykinin B2 receptors to promote calmodulin kinase II-mediated neuronal differentiation. Journal of biochemistry 20120701
New drugs 2012, part 2. Nursing 20120701
Differential regulation of collagen secretion by kinin receptors in cardiac fibroblast and myofibroblast. Toxicology and applied pharmacology 20120615
Safety and efficacy of icatibant self-administration for acute hereditary angioedema. Clinical and experimental immunology 20120601
Renin-angiotensin system inhibitors and angioedema: anesthetic implications. Current opinion in anaesthesiology 20120601
Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20120601
Update on treatment of hereditary angioedema. Asian Pacific journal of allergy and immunology 20120601
Successful perioperative management of a patient with C1 esterase inhibitor deficiency with a novel bradykinin receptor B2 antagonist. Anaesthesia and intensive care 20120501
Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States. Postgraduate medicine 20120501
Immunotherapy for primary immunodeficiency diseases. The Medical clinics of North America 20120501
[Upper airway obstruction caused by ACE inhibitor-induced angioedema]. Lakartidningen 20120401
Home treatment of hereditary angioedema with icatibant administered by health care professionals. The Journal of allergy and clinical immunology 20120301
Hereditary angioedema therapies in the United States: movement toward an international treatment consensus. Clinical therapeutics 20120301
Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy 20120201
Inflammatory skin responses induced by icatibant injection are mast cell mediated and attenuated by H(1)-antihistamines. Experimental dermatology 20120201
Dragon's blood inhibits chronic inflammatory and neuropathic pain responses by blocking the synthesis and release of substance P in rats. Journal of pharmacological sciences 20120101
[Hereditary angioedema]. La Revue du praticien 20120101
Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report. International journal of immunopathology and pharmacology 20120101
Bradykinin receptor 2 extends inflammatory cell recruitment in a model of acute gouty arthritis. Biochemical and biophysical research communications 20111216
[Angiotensin-converting enzyme inhibitor induced angioedema : new therapy options]. Der Anaesthesist 20111201
Abdominal surgical incision induces remote preconditioning of trauma (RPCT) via activation of bradykinin receptors (BK2R) and the cytochrome P450 epoxygenase pathway in canine hearts. Cardiovascular drugs and therapy 20111201
Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20111201
In brief: icatibant (Firazyr) for hereditary angioedema. The Medical letter on drugs and therapeutics 20111128
New topics in bradykinin research. Allergy 20111101
Bradykinin does not mediate remote ischaemic preconditioning or ischaemia-reperfusion injury in vivo in man. Heart (British Cardiac Society) 20111101
Cardiovascular and vasoconstrictive actions of skate bradykinin in the little skate, Leucoraja erinacea (Elasmobranchii). General and comparative endocrinology 20111101
The role of bradykinin and the effect of the bradykinin receptor antagonist icatibant in porcine sepsis. Shock (Augusta, Ga.) 20111101
[Bradykinin-mediated angioedema secondary to angiotensin converting enzyme: initiate treatment from the prehospital phase]. Annales francaises d'anesthesie et de reanimation 20111101
Insurers will find icatibant lifesaving but expensive treatment. Managed care once again faces the all-too-familiar debate about cost and benefit. Managed care (Langhorne, Pa.) 20111101
[Conestat alpha: effective but not practical]. La Revue du praticien 20111101
[Icatibant is a new treatment option in life-threatening angioedema triggered by angiotensin-converting enzyme inhibitor]. Ugeskrift for laeger 20111010
Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema. International journal of dermatology 20111001
Anti-nociceptive effect of kinin B₁ and B₂ receptor antagonists on peripheral neuropathy induced by paclitaxel in mice. British journal of pharmacology 20110901
Therapeutic approaches in hereditary angioedema. Clinical reviews in allergy & immunology 20110801
Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Management of adult patients with icatibant in hereditary angioedema. Emergency medicine journal : EMJ 20110801
One hypovolaemic shock…two kinin pathway abnormalities. Intensive care medicine 20110701
Upregulation of bradykinin receptors is implicated in the pain associated with caerulein-induced acute pancreatitis. Synapse (New York, N.Y.) 20110701
Treatment of acquired angioedema with icatibant: a case report. Internal and emergency medicine 20110601
Efficacy of icatibant treatment in patients with hereditary angio-oedema type I resistant to treatment with C1 inhibitor concentrate. The British journal of dermatology 20110601
Oversulfated chondroitin sulfate and OSCS-contaminated heparin cause dose- and route-dependent hemodynamic effects in the rat. Toxicological sciences : an official journal of the Society of Toxicology 20110601
Icatibant in hereditary angioedema: news and challenges. Expert review of clinical immunology 20110501
Tissue kallikrein protects cortical neurons against hypoxia/reoxygenation injury via the ERK1/2 pathway. Biochemical and biophysical research communications 20110408
Comparison of the molecular interactions of two antagonists, MEN16132 or icatibant, at the human kinin B₂ receptor. British journal of pharmacology 20110301
Rapid resolution of erythema marginatum after icatibant in acquired angioedema. Acta dermato-venereologica 20110301
The angiotensin II type 1 receptor antagonist Losartan binds and activates bradykinin B2 receptor signaling. Regulatory peptides 20110225
Acute NADPH oxidase activation potentiates cerebrovascular permeability response to bradykinin in ischemia-reperfusion. Free radical biology & medicine 20110215
Bradykinin and B₂ receptor antagonism in rat and human articular chondrocytes. British journal of pharmacology 20110201
Long-term prophylaxis of hereditary angioedema with androgen derivates: a critical appraisal and potential alternatives. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20110201
[Allergy-immunology. New therapies for acute attacks in hereditary angioedema]. Revue medicale suisse 20110119
Successful treatment of an acute attack of acquired angioedema with the bradykinin-B2-receptor antagonist icatibant. Journal of the European Academy of Dermatology and Venereology : JEADV 20110101
Hereditary angioedema: long-term treatment with one or more injections of C1 inhibitor concentrate per week. International archives of allergy and immunology 20110101
Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy. Cardiovascular diabetology 20110101
Update on the acute treatment of hereditary angioedema. Allergy and asthma proceedings 20110101
Bradykinin promotes migration and invasion of human immortalized trophoblasts. Reproductive biology and endocrinology : RB&E 20110101
Hereditary angioedema: management of laryngeal attacks. American journal of rhinology & allergy 20110101
Alteration in airway microvascular leakage induced by sensorineural stimulation in rats exposed to inhaled formaldehyde. Toxicology letters 20101215
Angioedema due to C1 inhibitor deficiency in 2010. Internal and emergency medicine 20101201
Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20101201
An overview of novel therapies for acute hereditary angioedema. American journal of clinical dermatology 20101201
Attenuation of persistent experimental pancreatitis pain by a bradykinin b2 receptor antagonist. Pancreas 20101101
Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant. Journal of the American Academy of Dermatology 20101101
Icatibant. Attacks of hereditary angioedema: continue to use C1 esterase inhibitor. Prescrire international 20101101
Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Annals of emergency medicine 20100901
Contribution of bradykinin B2 receptors to the inhibition by valsartan of systemic and renal effects of exogenous angiotensin II in salt-repleted humans. The Journal of pharmacology and experimental therapeutics 20100901
Hereditary angioedema: an update on available therapeutic options. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20100901
Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. The New England journal of medicine 20100805
Hereditary angioedema--therapies old and new. The New England journal of medicine 20100805
Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor. Investigative ophthalmology & visual science 20100701
Successful treatment of acquired C1 inhibitor deficiency with icatibant. Clinical and experimental dermatology 20100701
Tissue kallikrein promotes prostate cancer cell migration and invasion via a protease-activated receptor-1-dependent signaling pathway. Biological chemistry 20100701
Rapakinin, an anti-hypertensive peptide derived from rapeseed protein, dilates mesenteric artery of spontaneously hypertensive rats via the prostaglandin IP receptor followed by CCK(1) receptor. Peptides 20100501
Bradykinin receptor blockade reduces sympathetic nerve response to muscle contraction in rats with ischemic heart failure. American journal of physiology. Heart and circulatory physiology 20100501
[Emergency management of acute angioedema]. Deutsche medizinische Wochenschrift (1946) 20100501
Icatibant. British journal of clinical pharmacology 20100501
Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 20100401
Kinin B(1) and B(2) receptors contribute to orofacial heat hyperalgesia induced by infraorbital nerve constriction injury in mice and rats. Neuropeptides 20100401
MRP transporters as membrane machinery in the bradykinin-inducible export of ATP. Naunyn-Schmiedeberg's archives of pharmacology 20100401
Synthesis and bradykinin inhibitory activity of novel non-peptide compounds, and evaluation of in vivo analgesic activity. Bioorganic & medicinal chemistry 20100315
Comparison of the peripheral mediator background of heat injury- and plantar incision-induced drop of the noxious heat threshold in the rat. Life sciences 20100213
Bradykinin increases the secretion and expression of endothelin-1 through kinin B2 receptors in melanoma cells. Peptides 20100201
The role of kinin B1 and B2 receptors in the scratching behaviour induced by proteinase-activated receptor-2 agonists in mice. British journal of pharmacology 20100201
Proteinase-activated receptor-4 (PAR4) activation leads to sensitization of rat joint primary afferents via a bradykinin B2 receptor-dependent mechanism. Journal of neurophysiology 20100101
Icatibant. Drugs 20100101
Short-term prophylactic treatment of hereditary angioedema with icatibant. Allergy 20100101
Management of acute attacks of hereditary angioedema: potential role of icatibant. Vascular health and risk management 20100101
Both B1R and B2R act as intermediate signaling molecules in high glucose-induced stimulation of glutamate uptake in ARPE cells. Journal of cellular physiology 20091201
Effect of Intra-articular 4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido]-tetrahydro-2H-4-pyranylcarbonyl} piperazino)-5-oxopentyl](trimethyl)ammonium chloride hydrochloride (MEN16132), a kinin B2 receptor antagonist, on nociceptive response in monosodium iodoacetate-induced experimental osteoarthritis in rats. The Journal of pharmacology and experimental therapeutics 20091201
Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. The Journal of allergy and clinical immunology 20091201
Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2 receptor antagonism in human synovial fibroblasts. British journal of pharmacology 20091201
Icatibant for hereditary angioedema. Drugs of today (Barcelona, Spain : 1998) 20091201
Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20091101
Endogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysis. Journal of the American Society of Nephrology : JASN 20091001
Involvement of the kallikrein-kinin system in a model of hyperalgesia in low kallikrein rats. Veterinary research communications 20090901
Differential fading of inhibitory and excitatory B2 bradykinin receptor responses in rat sympathetic neurons: a role for protein kinase C. Journal of neurochemistry 20090901
B(2) kinin receptors mediate the Indian red scorpion venom-induced augmentation of visceral reflexes via the nitric oxide cyclic guanosine monophosphate pathway. Acta physiologica (Oxford, England) 20090801
Cardioprotective effect of sasanquasaponin preconditioning via bradykinin-NO pathway in isolated rat heart. Phytotherapy research : PTR 20090801
Scorpion toxin of Androctonus australis garzonii induces neuropeptide Y release via bradykinin stimulation in rat atria and kidneys. Peptides 20090801
Pharmacological characterization of the bradykinin B2 receptor antagonist MEN16132 in rat in vitro bioassays. European journal of pharmacology 20090801
Bradykinin receptor antagonists--a review of the patent literature 2005-2008. Expert opinion on therapeutic patents 20090701
When is prophylaxis for hereditary angioedema necessary? Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20090501
Effects of bradykinin on venous capacitance in health and treated chronic heart failure. Clinical science (London, England : 1979) 20090301
Triggering of proteinase-activated receptor 4 leads to joint pain and inflammation in mice. Arthritis and rheumatism 20090301
Bradykinin receptors antagonists and nitric oxide synthase inhibitors in vincristine and streptozotocin induced hyperalgesia in chemotherapy and diabetic neuropathy rat model. Neuro endocrinology letters 20090301
Bradykinin regulates calpain and proinflammatory signaling through TRPM7-sensitive pathways in vascular smooth muscle cells. American journal of physiology. Regulatory, integrative and comparative physiology 20090201
Bradykinin protects against oxidative stress-induced endothelial cell senescence. Hypertension (Dallas, Tex. : 1979) 20090201
The bradykinin B2 receptor mediates hypoxia/reoxygenation induced neuronal cell apoptosis through the ERK1/2 pathway. Neuroscience letters 20090123
Contrast-enhanced ultrasound in monitoring the efficacy of a bradykinin receptor 2 antagonist in painful knee osteoarthritis compared with MRI. Annals of the rheumatic diseases 20090101
Angiotensin II-mediated vasodilation is reduced in adult spontaneously hypertensive rats despite enhanced expression of AT2 receptors. Clinical and experimental pharmacology & physiology 20090101
Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema. Stroke 20090101
Salivary gland homogenates of Lutzomyia longipalpis and its vasodilatory peptide maxadilan cause plasma leakage via PAC1 receptor activation. Journal of vascular research 20090101
[Hereditary angioedema: a case series and bibliographic update]. Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 20090101
Bradykinin receptor antagonists and cyclooxygenase inhibitors in vincristine- and streptozotocin-induced hyperalgesia. Pharmacological reports : PR 20090101
Update on therapeutic developments for hereditary angioedema. Allergy and asthma proceedings 20090101
The protein therapy of kallikrein in cerebral ischemic reperfusion injury. Current medicinal chemistry 20090101
Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin. Hepato-gastroenterology 20090101
Hereditary angioedema: new hopes for an orphan disease. The Israel Medical Association journal : IMAJ 20081201
Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential. Circulation research 20081121
Vascular B1 kinin receptors in patients with congestive heart failure. Journal of cardiovascular pharmacology 20081101
Blockade of renal medullary bradykinin B2 receptors increases tubular sodium reabsorption in rats fed a normal-salt diet. American journal of physiology. Renal physiology 20080901
Therapeutic potential of icatibant (HOE-140, JE-049). Expert opinion on pharmacotherapy 20080901
Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts. Journal of cardiovascular pharmacology 20080801
Knee osteoarthritis: a role for bradykinin? Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20080801
B2 kinin receptor activation is the predominant mechanism by which trypsin mediates endothelium-dependent relaxation in bovine coronary arteries. Naunyn-Schmiedeberg's archives of pharmacology 20080701
Role of substance P and bradykinin in acute pancreatitis induced by secretory phospholipase A2. Pancreas 20080701
[Hereditary angioedema--treatment]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20080701
Retinal plasma extravasation in streptozotocin-diabetic rats mediated by kinin B(1) and B(2) receptors. British journal of pharmacology 20080501
Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model. American journal of physiology. Renal physiology 20080501
Role of tissue kallikrein in prevention and recovery of gentamicin-induced renal injury. Toxicological sciences : an official journal of the Society of Toxicology 20080401
Antihypertensive effects of crude extracts from leaves of Echinodorus grandiflorus. Fundamental & clinical pharmacology 20080401
ACE activity is modulated by kinin B2 receptor. Hypertension (Dallas, Tex. : 1979) 20080301
Analysis of the vasorelaxant action of angiotensin II in the isolated rat renal artery. Journal of pharmacological sciences 20080301
Inflammatory pain in the rabbit: a new, efficient method for measuring mechanical hyperalgesia in the hind paw. Journal of neuroscience methods 20080215
Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease. Neuroscience 20080206
Role of bradykinin, nitric oxide, and angiotensin II type 2 receptor in imidapril-induced angiogenesis. Hypertension (Dallas, Tex. : 1979) 20080201
MEN16132, a kinin B2 receptor antagonist, prevents the endogenous bradykinin effects in guinea-pig airways. European journal of pharmacology 20080128
Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion. Life sciences 20080116
Negative inotropic effect of selective AT2 receptor stimulation and its modulation by the endocardial endothelium. European journal of pharmacology 20080114
Effect of bradykinin receptor antagonists on vincristine- and streptozotocin-induced hyperalgesia in a rat model of chemotherapy-induced and diabetic neuropathy. Pharmacology 20080101
New therapies for hereditary angioedema: disease outlook changes dramatically. The Journal of allergy and clinical immunology 20080101
Hereditary angioedema: a current state-of-the-art review, II: historical perspective of non-histamine-induced angioedema. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20080101
Hereditary angiodema: a current state-of-the-art review, VI: novel therapies for hereditary angioedema. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20080101
Hereditary angioedema: a current state-of-the-art review, VIII: current status of emerging therapies. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20080101
Effects of the bradykinin B2 receptor antagonist icatibant on microvascular permeability after thermal injury in sheep. Shock (Augusta, Ga.) 20071201
[ACE-inhibitor induced angioedema]. Laryngo- rhino- otologie 20071101
ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats. American journal of physiology. Renal physiology 20071001
Endoplasmic reticulum is a key organella in bradykinin-triggered ATP release from cultured smooth muscle cells. Journal of pharmacological sciences 20070901
Bradykinin into amygdala induces thermal hyperalgesia in rats. Neuropeptides 20070801
Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. Cardiovascular research 20070701
C1-inhibitor deficiencies (hereditary angioedema): where are we with therapies? Current allergy and asthma reports 20070701
Peripheral kinin B(1) and B(2) receptor-operated mechanisms are implicated in neuropathic nociception induced by spinal nerve ligation in rats. Neuropharmacology 20070701
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proceedings of the National Academy of Sciences of the United States of America 20070619
Pharmacological and biochemical characterization of bradykinin B2 receptors in the mouse colon: influence of the TNBS-induced colitis. Regulatory peptides 20070607
Rapid modulation of micro-opioid receptor signaling in primary sensory neurons. The Journal of pharmacology and experimental therapeutics 20070601
Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). The Journal of allergy and clinical immunology 20070601
On the mechanism of coronary vasodilation induced by angiotensin-(1-7) in the isolated guinea pig heart. Basic & clinical pharmacology & toxicology 20070601
Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin. Investigative ophthalmology & visual science 20070501
[Practical management of C1 inhibitor deficiency]. Actas dermo-sifiliograficas 20070501
Functional characterization of the mechanisms underlying bradykinin-induced relaxation in the isolated rat carotid artery. Life sciences 20070417
Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction. Regulatory peptides 20070405
Bradykinin B(2) receptor does not contribute to blood pressure lowering during AT(1) receptor blockade. The Journal of pharmacology and experimental therapeutics 20070301
Bradykinin analogs containing the 4-amino-2-benzazepin-3-one scaffold at the C-terminus. Journal of peptide science : an official publication of the European Peptide Society 20070301
Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: involvement of bradykinin B2 and angiotensin AT1 receptors. Biological & pharmaceutical bulletin 20070301
Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload. Journal of the American College of Cardiology 20070220
Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension. Vascular pharmacology 20070201
Characterization of kinin receptors in human cultured detrusor smooth muscle cells. British journal of pharmacology 20070101
Bradykinin is a mediator, but unlikely a trigger, of antiarrhythmic effects of ischemic preconditioning. Journal of cardiovascular electrophysiology 20070101
The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors. European journal of pharmacology 20061203
Roles of leukocytosis and cysteinyl leukotriene in polymorphonuclear leukocyte-dependent plasma extravasation. Journal of leukocyte biology 20061201
Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant. Allergy 20061201
Renal cortical regulation of COX-1 and functionally related products in early renovascular hypertension (rat). American journal of physiology. Renal physiology 20061101
Angiotensin II type 2 receptor expression after vascular injury: differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blockade. Hypertension (Dallas, Tex. : 1979) 20061101
Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I. Canadian journal of physiology and pharmacology 20061101
Tissue kallikrein stimulates Ca(2+) reabsorption via PKC-dependent plasma membrane accumulation of TRPV5. The EMBO journal 20061018
Kinin modulation of conventional outflow facility in the bovine eye. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20061001
AT1 receptor blockade prevents microvascular dysfunction induced by ischemia/reperfusion injury. Journal of atherosclerosis and thrombosis 20061001
Kinins and neuroinflammation: dual effect on prostaglandin synthesis. European journal of pharmacology 20060928
Angiotensin-converting enzyme inhibitor-related angioedema: how to deal with it. Expert opinion on drug safety 20060901
Inhibition of angiotensin-converting enzyme reduces rat liver reperfusion injury via bradykinin-2-receptor. The Journal of surgical research 20060801
Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin. Blood 20060701
Ramipril treatment protects against nitrate-induced oxidative stress in eNOS-/- mice: An implication of the NADPH oxidase pathway. Journal of cardiovascular pharmacology 20060701
Role of bradykinin B2 receptors in the modulation of the peristaltic reflex of the guinea pig isolated ileum. European journal of pharmacology 20060606
Prostaglandin involvement in lung C-fiber activation by substance P in guinea pigs. Journal of applied physiology (Bethesda, Md. : 1985) 20060601
Substance P release evoked by capsaicin or potassium from rat cultured dorsal root ganglion neurons is conversely modulated with bradykinin. Journal of neurochemistry 20060601
Bradykinin mediates phosphorylation of eNOS in odontoblasts. Journal of dental research 20060601
Experimental therapy with tissue kallikrein against cerebral ischemia. Frontiers in bioscience : a journal and virtual library 20060501
Bradykinin antagonists modified with dipeptide mimetic beta-turn inducers. Bioorganic & medicinal chemistry letters 20060501
Peptide and non-peptide bradykinin receptor antagonists: role in allergic airway disease. European journal of pharmacology 20060308
Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20060301
Potentiation of nicotinic currents by bradykinin in the paratracheal ganglia neurons of rats. European journal of pharmacology 20060215
B(2)-receptor modulation of the reactivity to phenylephrine and angiotensin II in the carotid artery of normotensive rats after trandolapril treatment. Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 20060201
Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism. Journal of hypertension 20060101
Modulation of renal kallikrein by a high potassium diet in rats with intense proteinuria. Kidney international 20060101
Mechanism of non-capacitative Ca2+ influx in response to bradykinin in vascular endothelial cells. Journal of vascular research 20060101
Pharmacological enhancement of the kallikrein-kinin system promotes anti-fibrotic responses in human mesangial cells. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20060101
MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization. European journal of pharmacology 20051228
[Mechanism of cardioprotection against ischemia/reperfusion injury by valsartan: an experiment with isolated rat hearts]. Zhonghua yi xue za zhi 20051214
Activation of splanchnic and pelvic colonic afferents by bradykinin in mice. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20051201
Bradykinin B2 receptor antagonism attenuates inflammation, mast cell infiltration and fibrosis in remote myocardium after infarction in rats. Clinical and experimental pharmacology & physiology 20051201
Optical biosensor provides insights for bradykinin B(2) receptor signaling in A431 cells. FEBS letters 20051121
Does insulin release kinins in rats? European journal of pharmacology 20051121
MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs. The Journal of pharmacology and experimental therapeutics 20051101
A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass. Clinical pharmacology and therapeutics 20051101
Antagonistic effects of novel non-peptide chlorobenzhydryl piperazine compounds on contractile response to bradykinin in the guinea-pig ileum. European journal of pharmacology 20051031
Mechanisms involved in the nociception produced by peripheral protein kinase c activation in mice. Pain 20050901
The kallikrein-kinin system: current and future pharmacological targets. Journal of pharmacological sciences 20050901
Kinin and opioid receptors in the paratrigeminal nucleus modulate the somatosensory reflex to rat sciatic nerve stimulation. Peptides 20050801
Bradykinin B2 type receptor activation regulates fluid and electrolyte transport in the rabbit kidney. Peptides 20050801
Role of transient receptor potential vanilloid 1 receptors in adjuvant-induced chronic arthritis: in vivo study using gene-deficient mice. The Journal of pharmacology and experimental therapeutics 20050701
A possible alternative mechanism of kinin generation in vivo by cathepsin L. Biological chemistry 20050701
Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. European journal of pharmacology 20050615
Neuronal differentiation of P19 embryonal carcinoma cells modulates kinin B2 receptor gene expression and function. The Journal of biological chemistry 20050520
Bradykinin potentiates 5-HT3 receptor-mediated current in rat trigeminal ganglion neurons. Acta pharmacologica Sinica 20050401
Bradykinin upregulates IL-8 production in human gingival fibroblasts stimulated by interleukin-1beta and tumor necrosis factor alpha. Regulatory peptides 20050330
Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. The Journal of biological chemistry 20050304
Fate of bradykinin on the rat liver when administered by the venous or arterial route. Journal of gastroenterology and hepatology 20050301
CB(1) cannabinoid receptor stimulation modulates transient receptor potential vanilloid receptor 1 activities in calcium influx and substance P Release in cultured rat dorsal root ganglion cells. Journal of pharmacological sciences 20050301
Hit to Lead Success Stories--IBC Conference: Effective chemistry strategies for reducing attrition rates and speeding lead compounds into the pipeline. 31 January-1 February 2005, San Diego, CA, USA. IDrugs : the investigational drugs journal 20050301
Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium. The Journal of physiology 20050201
Altered renal response to acute volume expansion in transgenic rats harboring the human tissue kallikrein gene. Regulatory peptides 20050115
Icatibant: HOE 140, JE 049, JE049. Drugs in R&D 20050101
ACE inhibition lowers angiotensin-II-induced monocyte adhesion to HUVEC by reduction of p65 translocation and AT 1 expression. Journal of vascular research 20050101
Effects of bradykinin on cardiovascular remodeling in renovascular hypertensive rats. Hypertension research : official journal of the Japanese Society of Hypertension 20041101
Intracellular signalings underlying bradykinin-induced matrix metalloproteinase-9 expression in rat brain astrocyte-1. Cellular signalling 20041001
Bradykinin antagonists have no analgesic effect on incisional pain. Anesthesia and analgesia 20041001
Up-regulated neuronal nitric oxide synthase compensates coronary flow response to bradykinin in endothelial nitric oxide synthase-deficient mice. Journal of cardiovascular pharmacology 20041001
Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent. British journal of pharmacology 20040901
Mechanism of the endothelium-dependent vasodilation and the antihypertensive effect of Brazilian red wine. Journal of cardiovascular pharmacology 20040901
Pharmacological and histopathological characterization of Bothrops lanceolatus (Fer de lance) venom-induced edema. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20040701
Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors. Circulation research 20040625
Stimulation of cyclic GMP production via AT2 and B2 receptors in the pressure-overloaded aorta after banding. Hypertension (Dallas, Tex. : 1979) 20040601
Hoe 140 abolishes the blood pressure lowering effect of taurine in high fructose-fed rats. Amino acids 20040601
The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor. European journal of pharmacology 20040503
Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats. British journal of pharmacology 20040501
Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20040501
Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate. British journal of pharmacology 20040501
BK2 but not BK1 receptors mediating contractile response in human umbilical arteries: role of thromboxane A2. Methods and findings in experimental and clinical pharmacology 20040501
Angiotensin-(1-7) inhibits the angiotensin II-enhanced norepinephrine release in coarcted hypertensive rats. Regulatory peptides 20040415
Action of bradykinin in the submucosal plexus of guinea pig small intestine. The Journal of pharmacology and experimental therapeutics 20040401
Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats. British journal of pharmacology 20040401
Differential regulation of collecting duct Na+, K+-ATPase and K+ excretion by furosemide and piretanide: role of bradykinin. Journal of the American Society of Nephrology : JASN 20040401
The role of bradykinin in the antifibrotic actions of perindoprilat on human mesangial cells. Kidney international 20040401
Cell survival signalling in heart derived myofibroblasts induced by preconditioning and bradykinin: the role of p38 MAP kinase. Molecular and cellular biochemistry 20040401
Bradykinin and matrix metalloproteinases are involved the structural alterations of rat small resistance arteries with inhibition of ACE and NEP. Journal of hypertension 20040401
A new series of highly potent non-peptide bradykinin B2 receptor antagonists incorporating the 4-heteroarylquinoline framework. Improvement of aqueous solubility and new insights into species difference. Journal of medicinal chemistry 20040325
Role of bradykinin B2 and B1 receptors in the local, remote, and systemic inflammatory responses that follow intestinal ischemia and reperfusion injury. Journal of immunology (Baltimore, Md. : 1950) 20040215
Kinin B2 receptor is not involved in enalapril-induced apoptosis and regression of hypertrophy in spontaneously hypertensive rat aorta: possible role of B1 receptor. British journal of pharmacology 20040201
Modulation of allergic and immune complex-induced lung inflammation by bradykinin receptor antagonists. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20040201
Involvement of nitric oxide and prostaglandin pathways in the cardioprotective actions of bradykinin in rats with experimental myocardial infarction. Pharmacological research 20040101
Changes in vascular distensibility during angiotensin-converting enzyme inhibition involve bradykinin type 2 receptors. Journal of vascular research 20040101
Potential role of kinins in the effects of taurine in high-fructose-fed rats. Canadian journal of physiology and pharmacology 20040101
Icatibant: HOE 140, JE 049, JE049. Drugs in R&D 20040101
Infarct size limiting effect of apstatin alone and in combination with enalapril, lisinopril and ramipril in rats with experimental myocardial infarction. Pharmacological research 20031201
Converting enzyme inhibitor temocaprilat prevents high glucose-mediated suppression of human aortic endothelial cell proliferation. Journal of cardiovascular pharmacology 20031201
Protective effect of bradykinin antagonist Hoe-140 during in vivo myocardial ischemic-reperfusion injury in the cat. Regulatory peptides 20031015
Autoradiographic localization of [125I-Tyr0]bradykinin binding sites in brains of Wistar-Kyoto and spontaneously hypertensive rats. Cellular and molecular neurobiology 20031001
Amlodipine activates the endothelial nitric oxide synthase by altering phosphorylation on Ser1177 and Thr495. Cardiovascular research 20031001
Secretory dysfunction of vascular endothelium limits the effect of angiotensin converting enzyme inhibitor quinapril on aggregation of erythrocytes in experimental hypertension. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20030901
Kinins are involved in the development of allergic nasal hyperresponsiveness in guinea pigs. European journal of pharmacology 20030829
Bradykinin B2 receptors mediate contraction in the normal and inflamed human gallbladder in vitro. Gastroenterology 20030701
Changes in amino-terminal portion of human B2 receptor selectively increase efficacy of synthetic ligand HOE 140 but not of cognate ligand bradykinin. American journal of physiology. Heart and circulatory physiology 20030601
Metalloendopeptidases EC 3.4.24.15/16 regulate bradykinin activity in the cerebral microvasculature. American journal of physiology. Heart and circulatory physiology 20030601
Kininase I-type carboxypeptidases enhance nitric oxide production in endothelial cells by generating bradykinin B1 receptor agonists. American journal of physiology. Heart and circulatory physiology 20030601
AT1-receptor antagonism improves endothelial function in coronary artery disease by a bradykinin/B2-receptor-dependent mechanism. Hypertension (Dallas, Tex. : 1979) 20030501
Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells. Hypertension (Dallas, Tex. : 1979) 20030501
Enalaprilat, losartan and LU 135252 in coronary blood flow regulation. European journal of clinical investigation 20030501
Hyperalgesia induced by Asp49 and Lys49 phospholipases A2 from Bothrops asper snake venom: pharmacological mediation and molecular determinants. Toxicon : official journal of the International Society on Toxinology 20030501
Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury. British journal of pharmacology 20030501
Effect of a kinin B2 receptor antagonist on LPS- and cytokine-induced neutrophil migration in rats. British journal of pharmacology 20030501
Mechanism of kinin release during experimental acute pancreatitis in rats: evidence for pro- as well as anti-inflammatory roles of oedema formation. British journal of pharmacology 20030501
Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker. Circulation 20030415
Modulation of cutaneous inflammation by angiotensin-converting enzyme. Journal of immunology (Baltimore, Md. : 1950) 20030401
Amelioration of hyperalgesia by kinin receptor antagonists or kininogen deficiency in chronic constriction nerve injury in rats. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20030401
Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy. International immunopharmacology 20030301
Combined action of vasoactive amines and bradykinin mediates allergen-evoked thermal hyperalgesia in rats. European journal of pharmacology 20030221
Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin. Circulation 20030204
Angiotensin II and renal medullary blood flow in Lyon rats. American journal of physiology. Renal physiology 20030201
B2 bradykinin receptor mediates the stimulatory effect of bradykinin on rat germ cell proliferation in vitro. Andrologia 20030201
Differential modulation of murine lung inflammation by bradykinin B1 and B2 selective receptor antagonists. European journal of pharmacology 20030126
Characterisation of bradykinin B1 and B2 receptors using rat isolated vas deferens. European journal of pharmacology 20030105
Bradykinin B1 and B2 receptors differentially regulate cardiac Na+-H+ exchanger, Na+-Ca2+ exchanger and Na+-HCO3- symporter. European journal of pharmacology 20030101
Study of the mechanisms involved in the bradykinin-induced contraction of the pig iris sphincter muscle in vitro. European journal of pharmacology 20030101
Renoprotective effects of omapatrilat are mediated partially by bradykinin. American journal of nephrology 20030101
Effect of neutral endopeptidase inhibition on vascular response induced by exogenous angiotensin I in the isolated rat lung. Polish journal of pharmacology 20030101
Intrathecal bradykinin administration: opposite effects on nociceptive transmission. Pharmacology 20021001
Diuretic response to acute hypertension is blunted during angiotensin II clamp. American journal of physiology. Regulatory, integrative and comparative physiology 20021001
Bradykinin does not mediate cutaneous active vasodilation during heat stress in humans. Journal of applied physiology (Bethesda, Md. : 1985) 20021001
Remote preconditioning protects the heart by activating myocardial PKCepsilon-isoform. Cardiovascular research 20020815
In vivo bradykinin B2 receptor activation reduces renal fibrosis. The Journal of clinical investigation 20020801
Inhibition of angiotesin-converting enzyme by quercetin alters the vascular response to brandykinin and angiotensin I. Pharmacology 20020801
Interaction of linear and cyclic peptide antagonists at the human B(2) kinin receptor. Peptides 20020801
Bradykinin-induced neuropeptide Y release by human pheochromocytoma tissue. Neuropeptides 20020801
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers synergistically increase coronary blood flow in canine ischemic myocardium: role of bradykinin. Journal of the American College of Cardiology 20020703
Biocompatibility of thermosensitive chitosan-based hydrogels: an in vivo experimental approach to injectable biomaterials. Biomaterials 20020701
Bradykinin is involved in hyperalgesia induced by Bothrops jararaca venom. Toxicon : official journal of the International Society on Toxinology 20020701
Icatibant blocks but does not reverse ACE inhibitor renal effect in Goldblatt rabbit. Clinical and experimental hypertension (New York, N.Y. : 1993) 20020701
Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat. Kidney international 20020601
B1 and B2 antagonists and bradykinin-induced blood flow in rat skin inflammation. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20020601
Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells. Hypertension (Dallas, Tex. : 1979) 20020501
Myocardial blood flow after chronic cardiac decentralization in anesthetized dogs: effects of ACE-inhibition. Autonomic neuroscience : basic & clinical 20020418
Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. The Journal of clinical investigation 20020415
Synthesis and analysis of potent, more lipophilic derivatives of the bradykinin B2 receptor antagonist peptide Hoe 140. The journal of peptide research : official journal of the American Peptide Society 20020401
Cardiovascular effects of peptide kinin B2 receptor antagonists in rats. Canadian journal of physiology and pharmacology 20020401
Identification of bradykinin receptors in clinical cancer specimens and murine tumor tissues. International journal of cancer 20020301
Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment. Circulation 20020205
Role of kallikrein-kininogen system in insulin-stimulated glucose transport after muscle contractions. Journal of applied physiology (Bethesda, Md. : 1985) 20020201
Role of bradykinin in acid-induced mesenteric hyperemia and duodenal villous damage. Life sciences 20020104
Blockade of bradykinin B(2) receptor suppresses acute pancreatitis induced by obstruction of the pancreaticobiliary duct in rats. British journal of pharmacology 20020101
Pharmacological and functional characterization of the guinea-pig B2 bradykinin receptor stably expressed in CHO-K1 cell line. British journal of pharmacology 20020101
[Bradykinin antagonist: current status and perspective]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20020101
Neutral endopeptidase knockout induces hyperalgesia in a model of visceral pain, an effect related to bradykinin and nitric oxide. Journal of molecular neuroscience : MN 20020101
Palmitoylation of the human bradykinin B2 receptor influences ligand efficacy. Biochemistry 20011225
Interactive contribution of NK(1) and kinin receptors to the acute inflammatory oedema observed in response to noxious heat stimulation: studies in NK(1) receptor knockout mice. British journal of pharmacology 20011201
A potential role of bradykinin in angiogenesis and growth of S-180 mouse tumors. Japanese journal of pharmacology 20011201
Involvement of vanilloid receptor VR1 and prostanoids in the acid-induced writhing responses of mice. Life sciences 20011102
Human airway smooth muscle cells secrete vascular endothelial growth factor: up-regulation by bradykinin via a protein kinase C and prostanoid-dependent mechanism. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20011101
Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats. British journal of pharmacology 20011101
Analysis of the mechanisms involved in the inflammatory response induced by des-Arg9-bradykinin in the rat pleural cavity. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20011101
Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Circulation 20011030
Metalloendopeptidases EC 3.4.24.15 and EC 3.4.24.16 and bradykinin B2 receptors do not play important roles in renal wrap hypertension in rabbits. Clinical and experimental pharmacology & physiology 20011001
Bradykinin receptor antagonists attenuate neointimal proliferation postangioplasty. American journal of physiology. Heart and circulatory physiology 20011001
Hypoxia decreases lung neprilysin expression and increases pulmonary vascular leak. American journal of physiology. Lung cellular and molecular physiology 20011001
Age-dependent renal responses to the bradykinin B(2)- receptor antagonist icatibant in conscious lambs. American journal of physiology. Regulatory, integrative and comparative physiology 20011001
Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasia. The Journal of endocrinology 20011001
Effect of chronic blockade of the kallikrein-kinin system on the development of hypertension in rats. Hypertension (Dallas, Tex. : 1979) 20011001
Bradykinin facilitates noradrenaline spillover during contraction in the canine gracilis muscle. Canadian journal of physiology and pharmacology 20011001
Effects of two novel non-peptide antagonists at the rabbit bradykinin B2 receptor. Peptides 20010901
Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway. British journal of pharmacology 20010901
Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion. Hypertension (Dallas, Tex. : 1979) 20010901
The involvement of bradykinin in adrenaline-induced pulmonary edema in rats. Journal of medical and dental sciences 20010901
Pharmacological modulation of hyperalgesia induced by Bothrops asper (terciopelo) snake venom. Toxicon : official journal of the International Society on Toxinology 20010801
Absence of ligand-induced regulation of kinin receptor expression in the rabbit. British journal of pharmacology 20010801
Bradykinin B2, but not B1, receptor antagonism has a neuroprotective effect after brain injury. Journal of neurotrauma 20010801
Bradykinin B2 receptor is involved in the late phase of preconditioning in rabbit heart. Journal of molecular and cellular cardiology 20010701
Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat. British journal of pharmacology 20010601
Plasma extravasation mediated by lipopolysaccharide-induction of kinin B1 receptors in rat tissues. Mediators of inflammation 20010601
Bradykinin mediates the acute effect of an angiotensin-converting enzyme inhibitor on cerebral autoregulation in rats. Stroke 20010501
Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats. Hypertension (Dallas, Tex. : 1979) 20010501
Different potentiating effects of imidapril and enalapril on kaolin-induced writhing reaction in mice. Life sciences 20010413
Effects of bradykinin on renal nerve stimulation-induced antidiuresis and norepinephrine overflow in anesthetized dogs. Journal of cardiovascular pharmacology 20010401
Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinases. Japanese journal of cancer research : Gann 20010401
Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice. Circulation research 20010330
Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid. American journal of physiology. Regulatory, integrative and comparative physiology 20010301
Ace-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats. Journal of molecular and cellular cardiology 20010301
Differences between peptide and nonpeptide B(2) bradykinin receptor antagonists in blocking bronchoconstriction and hypotension induced by bradykinin in anesthetized Guinea pigs. The Journal of pharmacology and experimental therapeutics 20010301
Effects of icatibant on the ramipril-induced decreased in renal lithium clearance in the rat. Naunyn-Schmiedeberg's archives of pharmacology 20010301
Bradykinin evokes a Ca2+-activated chloride current in non-neuronal cells isolated from neonatal rat dorsal root ganglia. The Journal of physiology 20010201
Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo. Hypertension (Dallas, Tex. : 1979) 20010201
Role of bradykinin and tachykinins in the potentiation by enalapril of coughing induced by citric acid in pigs. Fundamental & clinical pharmacology 20010201
Postischemic anti-inflammatory effects of bradykinin preconditioning. American journal of physiology. Heart and circulatory physiology 20010101
Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen. The Journal of allergy and clinical immunology 20010101
Effect of bradykinin on cultured bovine corneal endothelial cells. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20010101
Enalaprilat attenuates ischemic rises in intracellular sodium in the isolated rat heart via the bradykinin receptor. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 20010101
The effect of agonists and antagonists on the morphology of non-transformed human smooth muscle cell in vitro. Journal of submicroscopic cytology and pathology 20010101
Benidipine, a long-acting Ca channel blocker, limits infarct size via bradykinin- and NO-dependent mechanisms in canine hearts. Cardiovascular drugs and therapy 20010101
Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum. European journal of pharmacology 20001208
In various tumour cell lines the peptide bradykinin B(2) receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist. British journal of pharmacology 20001201
Endogenous bradykinin and the renin and pressor responses to furosemide in humans. The Journal of pharmacology and experimental therapeutics 20001101
Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet. British journal of pharmacology 20000701
Neuropeptide Y enhances potassium excretion by mechanisms distinct from those controlling sodium excretion. Canadian journal of physiology and pharmacology 20000201
Characterization of bradykinin B(2) receptor antagonists in human and rat urinary bladder. European journal of pharmacology 20000128
Design and synthesis of potent bradykinin agonists containing a benzothiazepine moiety. Journal of medicinal chemistry 19991007
Pharmacological and molecular evidence for kinin B1 receptor expression in urinary bladder of cyclophosphamide-treated rats. British journal of pharmacology 19990901
Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts. The American journal of cardiology 19990617
Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P. Hypertension (Dallas, Tex. : 1979) 19980601
Role of kinins in the renoprotective effect of angiotensin-converting enzyme inhibitors in experimental chronic renal failure. Kidney & blood pressure research 19980101
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study. Hypertension (Dallas, Tex. : 1979) 19970401
Role of activation of bradykinin B2 receptors in disruption of the blood-brain barrier during acute hypertension. Brain research 19961104
The role of endogenous bradykinin in blood pressure homeostasis in spontaneously hypertensive rats. British journal of pharmacology 19960801
Substance P and capsaicin-induced mechanical hyperalgesia in the rat knee joint; the involvement of bradykinin B1 and B2 receptors. British journal of pharmacology 19960801
Ramiprilat attenuates hypoxia/reoxygenation injury to cardiac myocytes via a bradykinin-dependent mechanism. European journal of pharmacology 19960613
Cardiac growth during high and low dose perindopril treatment in spontaneously hypertensive rats. Clinical and experimental pharmacology & physiology 19960101
Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors. Journal of hypertension 19951201
Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension. Hypertension (Dallas, Tex. : 1979) 19950801
Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptor antagonists. Investigative ophthalmology & visual science 19950301
Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist. British journal of clinical pharmacology 19941001
Role of bradykinin in myocardial preconditioning. The Journal of pharmacology and experimental therapeutics 19940801
Characterization of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder. British journal of pharmacology 19940401
Bradykinin-induced sensitization of afferent neurons in the rat paw. Neuroscience 19940301
Bradykinin-induced activation of nociceptors: receptor and mechanistic studies on the neonatal rat spinal cord-tail preparation in vitro. British journal of pharmacology 19921201

© 2019 Angene International Limited. All rights Reserved.